Comparison of Low and Normal Flow Anesthesia in Robotic Assisted Radical Prostatectomy
The Effect of Low-flow and Normal-flow Desflurane Anesthesia on Respiratory Parameters in Robotic-assisted Radical Prostatectomy
1 other identifier
observational
68
1 country
1
Brief Summary
Robot-assisted laparoscopic radical prostatectomy has gained increasing popularity compared to open radical prostatectomy with its advantages such as low blood loss, reduced blood transfusion rate, low complication rate, and shortened hospital stay. Since robot-assisted laparoscopic radical prostatectomy should be performed in the limited retroperitoneal area, insufflation of the abdomen with carbon dioxide (CO2) (pneumoperitoneum) and steep Trendelenburg position are required to provide better surgical vision. Low-flow anesthesia warms and moistens the inhaled gases, creating a more physiological breathing atmosphere during anesthesia. In addition, it provides cost advantage by reducing inhalation agent consumption and reduces atmospheric pollution. Studies show that long-term minimal flow anesthesia is safe and advantageous for non-laparoscopic surgery. The aim of this study is to compare low-flow (1L/min) with normal flow (3lt/min) desflurane anesthesia in terms of hemodynamic and respiratory parameters, inhalation agent consumption and soda lime consumption for robotic assisted laparoscopic radical prostatectomy surgery. The secondary aim of the study is to compare the effects of low-flow and normal-flow anesthesia in the steep trendelenburg position (45°) used for robotically assisted laparoscopic radical prostatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 23, 2022
CompletedFirst Posted
Study publicly available on registry
August 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedAugust 26, 2022
August 1, 2022
1 month
August 23, 2022
August 24, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
inspiratory O₂ concentration
inspiratory O₂ concentration is measured from anesthesia machine monitor
from beginning of anesthesia induction to the end of anesthesia (during periopertaive period)
partial oxygen pressure
PO2 from blood gas analysis
from beginning of anesthesia induction to the end of anesthesia (during periopertaive period)
Secondary Outcomes (2)
desflurane consumption
perioperative
changes in liver and kidney function tests from the preoperative values to 48 hours postoperative
during operation and 48 hours postoperative
Study Arms (2)
normal flow anesthesia
A fresh gas flow of 3 L/min will be applied continuously
low flow anesthesia
A fresh gas flow of 3 L/min will be applied for the first 20 minutes after intubation , and then it will be reduced to 1 L/min.
Interventions
Patients who will undergo robotic-assisted laparoscopic prostatectomy surgery
Eligibility Criteria
Patients who will undergo robotic-assisted laparoscopic prostatectomy surgery
You may qualify if:
- \- ASA I-II risk group
You may not qualify if:
- ASA III, IV, V,
- concomitant serious cardiac, respiratory, hepatic, renal disturbance,
- mental status disorder and hearing problem,
- anxiety and depression and/or other psychiatric disorders,
- patient's refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara City Hospital
Ankara, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle Investigator
Study Record Dates
First Submitted
August 23, 2022
First Posted
August 26, 2022
Study Start
August 1, 2022
Primary Completion
September 1, 2022
Study Completion
March 1, 2023
Last Updated
August 26, 2022
Record last verified: 2022-08